Works matching AU Alffenaar, Jan-Willem C


Results: 91
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S560, doi. 10.1093/ofid/ofz360.1402
    By:
    • Martson, Anne-Grete;
    • Sturkenboom, Marieke G G;
    • Berger, Stefan P;
    • Damman, Kevin;
    • Verschuuren, Erik A M;
    • Blokzijl, Hans;
    • Bakker, Martijn;
    • Span, Lambert F R;
    • Touw, Daan J;
    • Werf, Tjip S van der;
    • Knoester, Marjolein;
    • Alffenaar, Jan-Willem C
    Publication type:
    Article
    16

    Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<sub>.</sub>.

    Published in:
    2020
    By:
    • Abdul-Aziz, Mohd H.;
    • Alffenaar, Jan-Willem C.;
    • Bassetti, Matteo;
    • Bracht, Hendrik;
    • Dimopoulos, George;
    • Marriott, Deborah;
    • Neely, Michael N.;
    • Paiva, Jose-Artur;
    • Pea, Federico;
    • Sjovall, Fredrik;
    • Timsit, Jean F.;
    • Udy, Andrew A.;
    • Wicha, Sebastian G.;
    • Zeitlinger, Markus;
    • De Waele, Jan J.;
    • Roberts, Jason A.;
    • Infection Section of European Society of Intensive Care Medicine (ESICM);
    • Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID);
    • Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT);
    • Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC)
    Publication type:
    journal article
    17

    Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 2, p. 421, doi. 10.1007/s00277-023-05091-y
    By:
    • Märtson, Anne-Grete;
    • da Silva Ferreira, Ana Rita;
    • Veringa, Anette;
    • Liu, Lei;
    • Wardill, Hannah R.;
    • Junier, Lenneke A. T.;
    • van der Werf, Tjip S.;
    • Harmsen, Hermie J. M.;
    • Sturkenboom, Marieke G. G.;
    • Span, Lambert F.;
    • Tissing, Wim J. E.;
    • Alffenaar, Jan-Willem C.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Reply to Verhaeghe et al.

    Published in:
    2016
    By:
    • Akkerman, Onno W.;
    • van Hateren, Kai;
    • Koster, Remco A.;
    • Luijckx, Gert-Jan R.;
    • van der Werf, Tjip S.;
    • Alffenaar, Jan-Willem C.
    Publication type:
    Letter to the Editor
    29

    The Never Ending Struggle Against Development of Drug Resistance.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 1, p. 137, doi. 10.1093/cid/civ238
    By:
    • Daskapan, Alper;
    • Stienstra, Ymkje;
    • Akkerman, Onno W.;
    • de Lange, Wiel C. M.;
    • Kosterink, Jos G. W.;
    • van der Werf, Tjip S.;
    • Alffenaar, Jan-Willem C.;
    • Narendran, Gopalan;
    • Swaminathan, Soumya
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational Study.

    Published in:
    Annals of Pharmacotherapy, 2025, v. 59, n. 4, p. 311, doi. 10.1177/10600280241271223
    By:
    • Patanwala, Asad E;
    • Abu Sardaneh, Arwa;
    • Alffenaar, Jan-Willem C;
    • Choo, Chui Lynn;
    • Dey, Alexandra L;
    • Duffy, Eamon J;
    • Green, Sarah E;
    • Hills, Thomas E;
    • Howle, Lisa M;
    • Joseph, Jessica A;
    • Khuon, Maxkirivan C;
    • Koppen, Cassandra S;
    • Pang, Francis;
    • Park, Jung Yeun;
    • Parlicki, Mark A;
    • Shah, Isha S;
    • Tran, Kylie;
    • Tran, Priscilla;
    • Wills, Mardi A;
    • Xu, Jessica H
    Publication type:
    Article
    47
    48
    49
    50

    Risk factors contributing to a low darunavir plasma concentration.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 3, p. 456, doi. 10.1111/bcp.13464
    By:
    • Daskapan, Alper;
    • Stienstra, Ymkje;
    • Kosterink, Jos G. W.;
    • Bierman, Wouter F. W.;
    • van der Werf, Tjip S.;
    • Touw, Daan J.;
    • Alffenaar, Jan-Willem C.
    Publication type:
    Article